Literature DB >> 6315439

Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy.

S D Pena, M Opas, K Turksen, V I Kalnins, S Carpenter.   

Abstract

Giant axonal neuropathy (GAN) is a severe autosomal recessive disease affecting both the peripheral and central nervous systems. It is characterized by segmental axonal ballooning due to large neurofilamentous masses and abnormal aggregation of filaments in other cell types including glial cells. Coomassie blue staining of the detergent-resistant cytoskeleton of cultured skin fibroblasts from three patients with GAN revealed the presence of large cytoplasmic filamentous aggregates in the great majority of cells. The aggregates were birefringent when viewed under polarization microscopy and electron microscopy showed that they were composed of aggregates of 8 to 10 nm intermediate filaments. The aggregates stained with antisera specific for vimentin but did not stain with antibodies to actin, tubulin, or the high molecular weight (HMW) microtubule associated protein. Examination of the fibroblasts containing the vimentin aggregates with antibodies to tubulin and the HMW protein showed that they had a normal distribution of microtubules and that the microtubules present were normally associated with the HMW protein. The results suggest that giant axonal neuropathy is a generalized inborn error of organization of intermediate filaments and that a defect in microtubules or their association with HMW protein is not responsible for the observed aggregation of intermediate filaments in this disease. Further study of GAN may be useful in understanding the function of intermediate filaments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315439

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  12 in total

1.  Giant axonal neuropathy: acceleration of neurofilament transport in optic axons.

Authors:  S Monaco; L Autilio-Gambetti; D Zabel; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

Authors:  A L Taratuto; G Sevlever; M Saccoliti; L Caceres; M Schultz
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

4.  Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease.

Authors:  Diane Armao; Rachel M Bailey; Thomas W Bouldin; Yongbaek Kim; Steven J Gray
Journal:  Clin Auton Res       Date:  2016-07-01       Impact factor: 4.435

5.  Sarcoplasmic-reticulum biogenesis in contraction-inhibited skeletal-muscle cultures.

Authors:  J H Charuk; C Guerin; P C Holland
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

6.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

7.  Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation.

Authors:  Arlene I Ramsingh; Steven J Gray; Andrew Reilly; Michael Koday; Debbie Bratt; Merika Treants Koday; Paul Munson; Robert Murnane; Jeremy Smedley; Yuhui Hu; Anne Messer; Deborah Heydenburg Fuller
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

8.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

9.  Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization.

Authors:  M W Klymkowsky; D J Plummer
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

10.  Explaining intermediate filament accumulation in giant axonal neuropathy.

Authors:  Puneet Opal; Robert D Goldman
Journal:  Rare Dis       Date:  2013-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.